The Impact of Secondary Hyperparathyroidism on the Efficacy of Antiresorptive Therapy

BMC Musculoskeletal Disorders - United Kingdom
doi 10.1186/1471-2474-13-244
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Usefulness of Intravenous Maxacalcitol Therapy for Secondary Hyperparathyroidism After Percutaneous Ethanol Injection Therapy (PEIT).

Nihon Toseki Igakkai Zasshi
2003English

Clinical Efficacy of 22-Oxacalcitriol Against Secondary Hyperparathyroidism in Hemodialysis Patients.

Nihon Toseki Igakkai Zasshi
1999English

Effects of the Antiresorptive Therapy on Bone Metabolic Activity in Postmenopausal Women

Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor
2012English

Role of Vitamin D in the Efficiency of Antiresorptive Therapy

Modern Rheumatology Journal
2009English

The Effects of Maxacalcitol Therapy for the Patients With Secondary Hyperparathyroidism on Clinical Symptoms, Bone Mineral Density and Parathyroid Swelling

Nihon Toseki Igakkai Zasshi
2007English

Role of Etelcalcetide in the Management of Secondary Hyperparathyroidism in Hemodialysis Patients: A Review on Current Data and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Secondary Hyperparathyroidism in Osteomalacia

BMJ
1970English

Vitamin D and Secondary Hyperparathyroidism in HIV Infected Patients Taking Antiretroviral Therapy

World Journal of AIDS
2014English

Secondary and Tertiary Hyperparathyroidism, State of the Art Surgical Management

Surgical Clinics of North America
Surgery
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy